@ARTICLE{
author={Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf},
year={2018},
title={Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={7},
pages={1535-1540},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin},
year={2018},
title={Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={28},
number={6},
pages={1153-1161},
document_type={Article},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Andric Zoran G,Kowalski Dariusz,Voisin Daniel,Rizzi Giada,Karthaus Meinolf},
year={2017},
title={Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={35},
number={31},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Andric Zoran G,Kowalski Dariusz,Voisin Daniel,Rizzi Giada,Karthaus Meinolf},
year={2017},
title={Phase 3 safety evaluation of an intravenous formulation of NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron},
journal={ANNALS OF ONCOLOGY},
volume={28},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Aapro Matti,Jordan Karin,Gralla Richard J,Rizzi Giada,Rossi Giorgia,Palmas Marco,Alyasova Anna V,Lisyanskaya Alla S,Bosnjak Snezana M,Hesketh Paul J},
year={2017},
title={Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients},
journal={JOURNAL OF GERIATRIC ONCOLOGY},
volume={8},
number={1},
pages={56-63},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Jordan Karin,Rizzi Giada},
year={2015},
title={Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) with Nepa, the First Oral Combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={25},
number={9},
pages={582-583},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Gralla RJ,Bosnjak Snezana M,Hontsa A,Balser C,Rizzi Giada,Rossi G,Borroni Maria Elisa,Jordan Karin},
year={2014},
title={A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={25},
number={7},
pages={1333-1339},
document_type={Article},
} 

@ARTICLE{
author={Gralla RJ,Bosnjak Snezana M,Balser C,Rizzi Giada,Borroni Maria Elisa,Rossi G,Jordan Karin},
year={2013},
title={Prevention of chemotherapy-induced nausea and vomiting (CINV) over repeated chemotherapy cycles: Results of a phase 3 trial of NEPA, a fixed oral dose combination of netupitant and palonosetron},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S267-S267},
document_type={Meeting Abstract},
}